Bureaucrats, developer, Administrators
9,842
edits
User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 14:00, 10 October 2021
, 10 October 2021fmt
(→Alzheimer's and cannabis: + File:Amyloid-beta.png + language fixes) |
m (fmt) |
||
| Line 24: | Line 24: | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234911/ ''''''Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy'''''' at ncbi.nlm.nih.gov], a '''2021''' review published in [[w:Biology (journal)]] | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234911/ ''''''Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy'''''' at ncbi.nlm.nih.gov], a '''2021''' review published in [[w:Biology (journal)]] | ||
* [https://pubmed.ncbi.nlm.nih.gov/33612548/ ''''''Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease'''''' at pubmed.ncbi.nlm.nih.gov], a 2021 study by researchers from [[w:Augusta University]] on CBD and and its effects on the [[w:TREM2]] and [[w:Interleukin 33]] proteins in Alzheimer's disease published in [[w:Journal of Alzheimer's Disease]] - "'' Our findings suggest that CBD treatment enhanced IL-33 and TREM2 expression, ameliorated the symptoms of AD, and retarded cognitive decline. ''" (ending sentence of the abstract) | * [https://pubmed.ncbi.nlm.nih.gov/33612548/ ''''''Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease'''''' at pubmed.ncbi.nlm.nih.gov], a '''2021''' study by researchers from [[w:Augusta University]] on CBD and and its effects on the [[w:TREM2]] and [[w:Interleukin 33]] proteins in Alzheimer's disease published in [[w:Journal of Alzheimer's Disease]] - "'' Our findings suggest that CBD treatment enhanced IL-33 and TREM2 expression, ameliorated the symptoms of AD, and retarded cognitive decline. ''" (ending sentence of the abstract) | ||
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970569/ ''''''A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC'''''' at ncbi.nlm.nih.gov], a '''2019''' literature review published in the [https://www.journal-jop.org/main.html Journal of Pharmacopuncture (JoP)] - "''These results implied that the CBD components of cannabis might be useful to treat and prevent AD because CBD components could suppress the main causal factors of AD. Moreover, it was suggested that using CBD and THC together could be more useful than using CBD or THC alone.''" (results section) | * [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970569/ ''''''A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC'''''' at ncbi.nlm.nih.gov], a '''2019''' literature review published in the [https://www.journal-jop.org/main.html Journal of Pharmacopuncture (JoP)] - "''These results implied that the CBD components of cannabis might be useful to treat and prevent AD because CBD components could suppress the main causal factors of AD. Moreover, it was suggested that using CBD and THC together could be more useful than using CBD or THC alone.''" (results section) | ||